Self-injections market seen reaching $15.05 billion by 2030

The self-injections market is projected to grow from $10.22 billion in 2025 to $11.04 billion in 2026, then reach $15.05 billion by 2030, according to The Business Research Company. Demand is being driven by diabetes, biologic drugs, home-based care and connected injection devices, with North America leading now and Asia-Pacific expected to grow fastest.

Why it matters: - The self-injections market is expanding as patients and providers shift toward more convenient, home-based treatment options. - Growth in diabetes and biologic therapies is increasing demand for devices that support self-administered care. - The market is also moving toward connected and digitally enhanced devices that aim to improve adherence, safety and dosing accuracy.

What happened: - The Business Research Company released its Self-Injections Global Market Report 2026, covering market size, trends and forecasts through 2035. - The report values the market at $10.22 billion in 2025 and $11.04 billion in 2026. - The report forecasts the market will reach $15.05 billion by 2030. - The report places the market at a compound annual growth rate of 8.1% across the forecast period. - The report says North America held the largest market share in 2025. - The report says Asia-Pacific will be the fastest-growing region during the forecast period. - The report covers Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East and Africa. - Download a free sample of the report. - View the full market report.

The details: - The report cites rising chronic disease cases, broader availability of injectable biologic drugs and growing demand for home-based treatments as key historical growth drivers. - The report also points to expansion in specialty pharmaceuticals and better device design and ergonomics. - The forecast outlook is supported by rising demand for self-care treatment options. - The report expects more adoption of injectors with digital health features. - The report expects continued expansion of biologic drug pipelines. - The report highlights greater focus on medication adherence through advanced drug delivery methods. - The report says connected medical devices will play a larger role in the market. - The report identifies auto-injector devices, wearable injection systems and patient-administered biologic therapies as key trends. - The report also points to patient-centric drug delivery innovation and improved safety and dosing accuracy. - Self-injection lets patients administer medication without help from healthcare professionals. - The approach is especially useful for chronic conditions that require regular injections. - The method can improve convenience and treatment adherence. - Diabetes remains a major driver because self-injection devices help patients administer insulin and other medications while managing blood sugar levels. - In November 2025, Diabetes Care reported that about 634.8 million adults, or 12.0% of the global adult population, had impaired glucose tolerance in 2024. - Diabetes Care projected that figure will rise to 846.5 million adults, or 12.9% of the global adult population, by 2050.

Between the lines: - The market story is shifting from basic injection hardware to more connected, patient-managed treatment systems. - Faster growth in Asia-Pacific suggests demand is spreading beyond mature healthcare markets. - The diabetes forecast underscores how chronic disease prevalence can translate into recurring device demand over many years. - The report’s emphasis on adherence and digital features suggests competition will center on outcomes as much as device mechanics.

What's next: - The market is expected to keep growing at 8.1% annually through 2030. - Device makers are likely to keep targeting auto-injectors, wearables and connected injection platforms. - Future growth will track biologic pipelines, diabetes prevalence and broader adoption of home treatment models. - The Business Research Company says its 2026 reports now include market attractiveness scoring, TAM analysis, company scoring matrices, Excel-based forecasting dashboards, market hotspot infographics and updated graphics and tables.